News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Geron Corporation (GERN) Grants License to Asia Biotech Corporation


3/12/2007 12:48:35 PM

MENLO PARK, Calif.--(BUSINESS WIRE)--Geron Corporation (Nasdaq:GERN) today announced it has granted an exclusive global license to Asia Biotech Corporation for the development of non-prescription dietary food supplements, nutraceuticals and cosmetics containing Geron’s small molecule telomerase activating compounds. Terms of the license were not disclosed.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES